Clear Search sequence regions


  • cancer (8)
  • female (1)
  • genotypes (2)
  • humans (1)
  • lesions cervix (1)
  • lymph node (1)
  • metastasis (1)
  • patient (2)
  • protein human (1)
  • research (1)
  • rs11547635 (1)
  • rs9619311 (3)
  • rs9862 (2)
  • taiwan (2)
  • TIMP- 3 (8)
  • timp3 protein (1)
  • women (5)
  • Sizes of these terms reflect their relevance to your search.

    Single nucleotide polymorphisms (SNPs) of tissue inhibitor of metalloproteinases-3 (TIMP-3) have been revealed to be related to various cancers. To date, no study explores the relationships between TIMP-3 polymorphisms and uterine cervical cancer. The purposes of this research were to investigate the associations among genetic variants of TIMP-3 and development and clinicopathological factors of uterine cervical cancer, and patient 5 years survival in Taiwanese women. The study included 123 patients with invasive cancer and 97 with precancerous lesions of uterine cervix, and 300 control women. TIMP-3 polymorphisms rs9619311, rs9862 and rs11547635 were checked and their genotypic distributions were determined by real-time polymerase chain reaction. It showed that women with genotypes CT/TT in rs9862 were found to display a higher risk of developing cervical cancer with moderate and poor cell differentiation. Moreover, it revealed that cervical cancer patients carrying genotypes CC in rs9619311 exhibited a poorer 5 years survival, as compared to those with TT/TC in Taiwanese women, using univariate analysis. In addition, pelvic lymph node metastasis was determined to independently predict 5 years survival in cervical cancer patients using multivariate analysis. Conclusively, TIMP-3 SNPs polymorphisms rs9619311 are related to cervical patient survival in Taiwanese women. © The author(s).

    Citation

    Jui-Fu Chung, Chia-Lin Chen, Yasser Nassef, Bei-Hao Shiu, Chun-Hao Wang, Fu-Hsuan Kuo, Yi-Hsuan Hsiao, Shun-Fa Yang, Po-Hui Wang. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan. International journal of medical sciences. 2022;19(6):1013-1022

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35813301

    View Full Text